Imbio Partners with Heart&Lung Health Ltd to Serve the UK Market with Enhanced Quantitative Imaging Services

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

April 6, 2021

The company is a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, and Heart&Lung Health, a leading cardiothoracic consultancy firm.

Today they announced their partnership to integrate Imbio AI algorithms within subspecialty radiology workflows to identify lung and cardiac conditions in patients across the United Kingdom.

“We are delighted to integrate the Imbio quantitative imaging technology into our routine practice to augment reporting of CT thorax studies of patients with potential lung diseases. Our interstitial lung disease CT scans may be acquired from numerous institutions that each have various scanners and protocols. Imbio can integrate this into a fluid workflow. Applying innovative technology to our routine clinical practice allows us to deliver rapid, reliable, and uniquely subspecialist imaging reports. This Imbio partnership aligns seamlessly with our mission to bring even more personalized care to patients,” said Heart&Lung Health.

Heart&Lung Health provides specialty radiology services for NHS trusts, private healthcare providers, and academic institutions across the UK. This partnership equips their expert cardiothoracic radiologists with quantitative imaging that provides data-driven insights to benefit patient outcomes. With automated results available upon receipt of the scans, Imbio serves as an aid for CT imaging assessment of cardiothoracic conditions without any additional steps by the radiologist.

“It has been rewarding to see the real-world clinical utilization of Imbio algorithms being realized in the United Kingdom with the Heart&Lung team. Partnering with world class cardiothoracic radiologists is an honor but facilitating an improved efficiency in their workflow for the combined mission of improving patient care is a privilege. Imbio technology will assist Heart&Lung in caring for thoracic patients in the UK,” said Dave Hannes, CEO at Imbio.

Through this partnership, Heart&Lung can further deliver on their vision of accurate and early diagnosis for lung and cardiac conditions where early interventions are key. Imbio can provide invaluable insights that allow Heart&Lung to further advocate on behalf of patients facing chronic lung diseases. By supporting radiology departments with rapid diagnosis and early disease detection, clinicians can facilitate the best treatment plan for their patients.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.